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Abstract 
Background: Sudden cardiac death is a leading cause of death in patients with ST-elevation 
myocardial infarction (MI). According to high cost of modern therapeutic modalities it is of 
paramount importance to define protocols for risk stratification of post-MI patients before 
considering   expensive   devices   such   as   implantable   cardioverter-defibrillator.
Methods: One hundred and thirty seven patients with acute ST-elevation MI were selected and 
underwent echocardiographic study, holter monitoring and signal-averaged electrocardiography 
(SAECG).   Then,   the   patients   were   followed   for   12   ±3   months.
Results: During follow-up, 13 deaths (9.5%) occurred; nine cases happened as sudden cardiac 
death (6.6%). The effect of ejection fraction (EF) less than 40% on occurrence of arrhythmic 
events was significant (P<0.001). Sensitivity and positive predictive value of EF<40% was 
100% and 76.95% respectively. Although with lesser sensitivity and predictive power than 
EF<40%, abnormal heart rate variability (HRV) and SAECG had also significant effects on 
occurrence of sudden death (P=0.02 and P=0.003 respectively). Nonsustained ventricular 
tachycardia was not significantly related to risk of sudden death in this study (P=0.20).
Conclusions:  This study indicated that EF less than 40% is the most powerful predictor of 
sudden cardiac death in post MI patients. Abnormal HRV and SAECG are also important 
predictors and can be added to EF for better risk stratification. 
Key Words:  myocardial infarction; sudden death; risk stratification; heart rate variability; 
signal-averaged electrocardiography; ejection fraction; non-sustained ventricular tachycardia
Introduction
            Arrhythmic cardiac events are a common cause of death in patients with ST-elevation 
myocardial infarction (MI) and perhaps the most preventable cause. Due to large number of 
these  patients and high cost  of implantable cardioverter-defibrillator  (ICD)  implantation, 
selection of eligible patients is very important. Factors such as low ejection fraction (EF), 
abnormal signal-averaged electrocardiogram (SAECG), abnormal heart  rate  variability  (HRV), 
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nonsustained ventricular tachycardia (NSVT) and T-wave alternans (TWA) have been used for 
risk  stratification  of   postMI   patients.1-3  Among  them  EF   seems  to  be  more  important.
            However it is not practical to select patients based on low EF alone because too many 
patients would be ICD candidates.4 On the other hand other methods such as SAECG and HRV 
seem to have additive value to low EF when they are used together.5,6 The purpose of this study 
was to determine value of low EF, abnormal SAECG, HRV, and NSVT as the risk factors of 
post MI sudden cardiac death as well as the effect of revascularization on reducing the risk of 
arrhythmic   death   in   these   patients.                                                      
Methods
Patient   characteristics                                                                      
            Included were 137 patients admitted with diagnosis of acute ST-elevation MI in coronary 
care units at our institution. The study was approved by the local Ethics Committee, and written 
informed consents were obtained from all the included patients. None of the patients included in 
this   study   had   standard   class   I   indication   for   ICD   implantation.                  
            Acute ST-elevation MI requires all of the following three criteria: (1) Chest pain: more 
than 30 minutes or equivalent symptoms; (2) ECG: ≥0.1 mV ST-elevation in two adjacent limb 
leads, and/or ≥0.2 mV ST elevation in two adjacent precordial leads, or left bundle branch block, 
or appearance of new Q-waves (≥0.03 s); (3) Enzymes: CK-elevation (≥ twice the upper normal 
limit) and CK-MB >24 units/l, or troponin positive. All patients underwent echocardiographic 
study, 24-hr ambulatory electrocardiography and SAECG at fifth or sixth day of admission. 
Mean age at time of study was 59.5±11.3 years (range 32-90 years), and 76.6% of the patients 
were males. Seventy-one patients (51.8%) experienced anterior MI and 66 patients (48.2%) had 
inferior/posterior MI. The patients were followed for 12±3 months. After completion of follow-
up period, information about life status, possible arrhythmias and probable revascularization 
extracted from their medical records or via telephone call or interview.                           
Holter   recording                                                                              
            Each patient underwent 24-hour Holter recording (VISTA®, Novacor, France). During 
Holter recording, patients were asked to note the timing if any symptom occurred. To check for 
NSVT, we used a full-disclosure method that allowed review of all 24-hour of ECG recording. A 
cardiologist, blinded to presenting symptom read the reports and ECG printouts of arrhythmias 
during symptomatic and asymptomatic episodes. NSVT was defined as occurrence of three or 
more consecutive premature ventricular beat with rate of ≥100 bpm and abnormal HRV as 
SDNN   ≤   70   ms.                                                                  
Signal-averaged  electrocardiography                                                                       
               The SAECG was recorded using a commercially available system (Hellige EK 56; 
Marquette Hellige, Freiburg, Germany). Before SAECG recording, the skin was prepared by 
shaving, removing skin debris with alcohol, and abrading the skin with gauze. The SAECG was 
recorded with standard bipolar X, Y, and Z orthogonal leads. Signals were amplified, averaged, 
and filtered with a bidirectional filter at frequencies of 40-250 Hz. About 200 beats were 
averaged to a noise level of <0.5 µV before signal amplification and filtering. The filtered 
signals were combined into a vector magnitude V and the QRS duration, the duration of low 
amplitude signals < 40 µV (LAS 40), and the root mean square voltage of the signals in the last 
40 ms of the filtered QRS (RMS 40) were calculated.                                       
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            The SAECG was considered to be abnormal if two of the following three criteria were 
met: (1) total filtered QRS duration > 114 ms; (2) RMS 40 < 20 µV; and (3) LAS 40 > 38 ms. 
Otherwise, the SAECGs were classified as normal.7                                                                 
Echocardiography
               Standard echocardiography with Doppler studies was performed (Vivid 7, General 
Electric, USA). Left ventricular (LV) end-systolic and diastolic dimensions and volumes and 
LVEF were measured by two-dimensional guided M-mode echocardiography according to the 
guidelines of the American Society of Echocardiography.8                                                   
Statistical   analysis                                                                
            Continuous data are presented as mean±SD and ranged when appropriate. Continuous 
variables   were   compared   by  Student’s   t-test  in  case   of   normal   distribution.   Otherwise, 
nonparametric test of Mann-Whitney U was used. Chi-square analysis was used for categorical 
data and Fisher exact test for cell count less than five. Sensitivity, specificity, positive predictive 
value, and negative predictive value of EF, SAECG, HRV, and nonsustained VT were measured 
according to standard formula and ROC curve analysis. A two-tailed P-value < 0.05 was defined 
statistically significant. The software SPSS version 13.0 (SPSS Inc., Chicago, Illinois) was used 
for   statistical   analysis.                                                                  
Results
            Mean age of patients at time of study was 59.5±11.3 years, and 76.6% of the patients 
were males. Seventy-one patients (51.8%) experienced anterior MI and 66 patients (48.2%) had 
inferior/posterior MI (Table 1). The patients were followed for 12±3 months. There were 13 
deaths in the follow-up period. Nine of these deaths (69%) occurred suddenly. Of these 9 
patients, one-third of sudden cardiac deaths (SCD) occurred in the first week (3-5 days) after MI 
and, in remaining two-thirds, 3 to 6 months after MI. Sensitivity, specificity, and positive 
predictive value of low EF, abnormal SAECG, abnormal HRV, and presence of NSVT in 
ambulatory electrocardiography were summarized in Table 2 and detailed below.
Table 1: Characteristics of study population
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Table 2: Sensitivity, specificity, and positive predictive value of myocardial infarction-related 
sudden cardiac death risk factors
Abbreviations: EF=ejection fraction; SAECG=signal averaged electrocardiography; 
HRV=heart rate variability; NSVT=nonsustained ventricular tachycardia
 
Value of ejection fraction for postMI risk stratification                                                         
            All the patients with arrhythmic events had ejection fraction of less than 40%. Sensitivity 
and specificity of EF<40% for predicting arrhythmic events was 100% and 54%, respectively 
(P<0.001).  Using ROC analysis, the probability of predicting SCD by an ideal observer based 
on   EF<40%   is   76.95%   (chance   level:   50%)                                                      
\
Value of SAECG for post MI risk stratification                                                       
            Sensitivity and specificity of abnormal SAECG for predicting arrhythmic events is 67% 
and 75% respectively (P=0.0034). The probability of predicting SCD based on abnormal 
SAECG by an ideal observer is 70.83 (chance level: 50%).                                                 
Value of HRV for post MI risk stratification                                                         
               Abnormal HRV has sensitivity and specificity of 67% and 66% respectively for 
predicting SCD in post MI patients (P=0.025). Positive predictive value of abnormal HRV is 
66.15   (chance   level:   50%).                                                                        
Value of NSVT for post MI risk stratification                                                           
            NSVT in this study was not significantly related to arrhythmic cardiac events (P=0.205).
Effect   of   revascularization   on   incidence   of   MI-related   sudden   cardiac   death          
               The probability of revascularization in patients with arrhythmic events and without 
arrhythmic events was 11% and 41%, respectively. These two probabilities are significantly 
different (P=0.036). The probability of SCD in patients who underwent revascularization was 
2%, while in patients without revascularization it was 10%. Again these two chances are 
significantly different (P=0.03). Subgroup analysis showed that only CABGs was associated 
with significant reduction of fatal arrhythmias in post MI patients (P=0.029). In percutaneous 
coronary intervention (PCI) group the relationship between angioplasty and arrhythmia reduction 
was   not   significant   (P=0.11).                                                            
Effect   of   thrombolytics   on   incidence   of   MI-related   sudden   cardiac   death              
            The chance of SCD in patients who received streptokinase was 4% and in those who did 
not receive streptokinase it was 8%. But this relationship was not statistically significant  
(P=0.178).
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 7(1): 19-25 (2006)Majid Haghjoo, Reza Kiani, Amir Farjam Fazelifar, Abolfath Alizadeh,                  23 
Zahra Emkanjoo, Mohammad Ali Sadr-Ameli, “Early Risk stratification for Arrhythmic 
death in Patients with ST-Elevation Myocardial Infarction” 
Discussion
               In this study, EF<40% was the strongest predictor of arrhythmic events in postMI 
patients with sensitivity of 100%.  However, specificity of EF<40% is low (54%) and this limits 
ICD case selection based on low ejection fraction alone. The same result was obtained in several 
studies.9-14  All of these studies have shown that left ventricular ejection fraction predicts 
outcome. Reduced left ventricular ejection fraction in most of these studies proved to be the most 
consistent   independent   risk   factor   for   cardiac   death   in   multivariate   analyses.  
            SAECG and HRV are also significantly related to arrhythmic events but they seem to 
have lesser predicting power than EF<40%. For evaluating additive value of SAECG and HRV 
on predictive power of EF<40%, we designed a logistic model based on EF and then another 
model constructed based on EF plus SAECG and HRV. The two models were compared using 
likelihood ratio test and observed that the additional value of SAECG and HRV on EF<40% is 
marginally significant (P=0.036). Presence of late potentials and abnormal HRV have been 
correlated with the inducibility of VT and their prognostic value in post MI patients have also 
been established in previous studies.15-20 However, results of recent studies leads to the SAECG 
having   fallen   out   of   favor   recently.21                                                               
            In our study NSVT was not a predictor for post MI sudden death. This result is in 
contrast with result of the Munich and Berlin Infarction Study.22 In the latter study, a Holter 
recording was performed in 1202 post MI patients before hospital discharge. Fourteen percent of 
patients with documented NSVT either died suddenly or developed symptomatic sustained VT 
or ventricular fibrillation (VF) within the next two years, compared with only 3.5% of patients 
without documentation of NSVT. The predictive value of rapid NSVT was even more 
impressive: if the rate of non-sustained ventricular tachycardia was ≥150 bpm (prevalence 
3.7%), the rate of either sudden death or sustained ventricular tachyarrhythmias (VT or VF) was 
22%, the relative risk being six times higher than the risk of patients without demonstration of 
rapid NSVT.23 Therefore, lack of efficacy of NSVT for SCD prediction in our study may be 
explained   by   the   definition   used   for   NSVT   in   Holter   and   duration   of   recording.    
               The study showed significant reduction of arrhythmic events by revascularization. 
Further analysis showed that only CABGs was associated with significant reduction of fatal 
arrhythmias in post MI patients (P=0.029). In PCI group the relationship between angioplasty 
and arrhythmia reduction was not significant (P=0.11) although a trend toward reducing the risk 
was observed. Although TIMI-3 flow was achieved in all patients who had PCI, we think that 
this finding may be explained by relatively small number of patients (only 13%) and incomplete 
revascularization in PCI group. Again in patients received thrombolytic therapy in acute phase of 
MI,  there  was  no  significant  decrease  in  arrhythmic  cardiac  events  (P=0.178).            
Conclusions
            Left ventricular EF less than 40% is the most important predictor of arrhythmic death 
among post MI patients. However, due to low specificity, other factors such as SAECG and 
HRV must be added to low EF for better risk stratification. NSVT was not significantly related 
to arrhythmic events in this study. Revascularization significantly reduces risk of sudden death in 
post MI patients. However only CABGs had meaningful effect on arrhythmic events and PCI 
failed to show this effect.
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